Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - glucagone - diabete mellito - ormoni pancreatici, glycogenolytic ormoni - baqsimi è indicato per il trattamento di ipoglicemia grave negli adulti, adolescenti e bambini di età compresa tra i 4 anni e oltre con diabete mellito.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenti antineoplastici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabete mellito, tipo 2 - farmaci usati nel diabete - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 e 5.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - colite, ulcerosa - immunosoppressori - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Ιταλία - Ιταλικά - Ministero della Salute

syngenta italia s.p.a. - captano; - polvere - 50.0 g i valori indicati sono per 100 g di prodotto. - fungicida - fungicida - (t) tossico

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

orion corporation - entacapone - morbo di parkinson - farmaci anti-parkinson - entacapone è indicato come coadiuvante di preparazioni standard di levodopa / benserazide o levodopa / carbidopa per l'uso in pazienti adulti con malattia di parkinson e le fluttuazioni motorie fine-di-dose, che non può essere stabilizzato con quelle combinazioni.

Ιταλία - Ιταλικά - AIFA (Agenzia Italiana del Farmaco)

vemedia manufacturing b.v. - paracetamolo, associazioni escl. psicolettici - paracetamolo, associazioni escl. psicolettici

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - emicrania - analgesici - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - linfoma, cellule del mantello - inibitori della proteina chinasi - treatment of mantle cell lymphoma (mcl).

Ιταλία - Ιταλικά - Ministero della Salute

ciba vision corporation - lenti a contatto